Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Change in Cash: 2020-2025

Historic Change in Cash for InMed Pharmaceuticals (INM) over the last 6 years, with Jun 2025 value amounting to $4.5 million.

  • InMed Pharmaceuticals' Change in Cash fell 76.50% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 424.43%. This contributed to the annual value of $4.5 million for FY2025, which is 292.42% up from last year.
  • As of FY2025, InMed Pharmaceuticals' Change in Cash stood at $4.5 million, which was up 292.42% from -$2.3 million recorded in FY2024.
  • Over the past 5 years, InMed Pharmaceuticals' Change in Cash peaked at $4.5 million during FY2025, and registered a low of -$2.3 million during FY2024.
  • Over the past 3 years, InMed Pharmaceuticals' median Change in Cash value was $2.7 million (recorded in 2023), while the average stood at $1.6 million.
  • Per our database at Business Quant, InMed Pharmaceuticals' Change in Cash spiked by 330.61% in 2023 and then tumbled by 185.57% in 2024.
  • Over the past 5 years, InMed Pharmaceuticals' Change in Cash (Yearly) stood at $1.6 million in 2021, then plummeted by 176.17% to -$1.2 million in 2022, then spiked by 330.61% to $2.7 million in 2023, then plummeted by 185.57% to -$2.3 million in 2024, then skyrocketed by 292.42% to $4.5 million in 2025.